Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This manuscript presents a protocol for establishing a mouse abdominal aortic aneurysm model using calcium chloride and elastase, combining the advantages of previous modeling methods. This model can be utilized to investigate the pathophysiological mechanisms underlying abdominal aortic aneurysms.

Abstract

Abdominal aortic aneurysm (AAA) is a life-threatening disease associated with high mortality rates. It is characterized by the permanent dilation of the abdominal aorta with at least a 50% increase in arterial diameter. Various animal models of AAA have been introduced to mimic the pathophysiological changes and study the underlying mechanisms of AAA. Among these models, the calcium chloride (CaCl2)- and elastase-induced AAA models are commonly used in mice. However, these methods have certain limitations. Traditional intraluminal porcine pancreatic elastase (PPE) perfusion is associated with high technical difficulty and a high rupture rate, while periadventitial administration of PPE yields inconsistent results. In addition, the CaCl2-induced AAA model lacks human AAA features, such as atherothrombosis and aneurysm rupture. Therefore, the combined application of CaCl2 and PPE has been proposed as an approach to enhance success rates and induce greater diameter increases in AAA animal models. This manuscript presents a comprehensive protocol for establishing a mouse AAA model through periaortic infiltration of PPE and CaCl2 in the infrarenal segment of the abdominal aorta. By following this protocol, we can achieve an AAA formation rate of approximately 90% with technical simplicity and reproducibility. Further ultrasound and histological experiments confirm that this model effectively replicates the morphological and pathological changes observed in human AAA.

Introduction

Abdominal aortic aneurysm (AAA) is defined as a diameter increase of more than 50% or a maximum aortic diameter exceeding 3 cm in the abdominal aorta. This condition poses a significant threat to life, with around a 90% mortality rate upon aneurysm rupture1,2,3. Currently, open surgical repair and endovascular aortic repair (EVAR) are the only available interventions for AAA patients4,5,6. However, there is insufficient evidence to support the effectiveness of medical treatments in i....

Protocol

The animal experiment protocol complied with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Pub No. 86/23, 1985) and was approved by the Institutional Animal Care and Use Committee of West China Hospital, Sichuan University (Approval Number 202311300012). Eight to ten-week-old C57/B6J male mice were used for this study. The details of the reagents and equipment used are listed in the Table of Materials.

1. Preoperative preparation<.......

Representative Results

In this study, a total of 24 mice were included and randomly assigned: 12 in the Sham group and 12 in the PPE + CaCl2 group, respectively. All data are presented as means ± standard deviations unless otherwise stated. The average operation time was 55.67 min ± 4.08 min. There were no intra-operative deaths or aneurysm ruptures, and the survival rate within 21 days after surgery was 100%. No severe intestinal adhesions or complications related to abdominal aorta dissection were observed.

Discussion

Research into the molecular mechanisms of AAA requires a stable animal model. Consequently, numerous AAA animal models have been established since its initial development by Economou et al. in the 1960s29. Among these models, CaCl2 is frequently employed in rodents due to its cost-effectiveness, technical simplicity, and reliable reproducibility. However, perivascular CaCl2 infiltration has been shown to be unstable in establishing AAA. Bi et al. and Freestone et al. reported.......

Acknowledgements

This work was supported by the National Natural Science Foundations of China (No. 82300542, 81770471), Sichuan Science and Technology Program (No. 2022YFS0359, 2019JDRC0104) and Post-Doctor Research Project, West China Hospital, Sichuan University (No. 2023HXBH108). The funding bodies played no role in the design of the study, the collection, analysis, and interpretation of the data, and the writing of the manuscript.

....

Materials

NameCompanyCatalog NumberComments
Anesthesia MachineRWDR550
ButorphanolJiangsu Hengrui Pharmaceutical Co., Ltd220608BP1ml: 1mg
C57BL/6JGpt Male MiceGemPharmatechN000013
Calcium ChlorideSigma AldrichC4901100 g
CarprofenMCEHY-B1227100 mg
Chow DietDossy Experimental Animals Co.Ltd
Digital CaliperGreenerIP54
EthanolJinhe Pharmaceutical Co.Ltd53968275%/500 mL
EVG Staining KitSolarbioG1597
GraphPad PrismGraphpadVer 9.0.0
H&E Staining KitServicebioG1076
Insulin SyringeBD2143420
IsofluraneRWDR510-22-4100 mL
Masson Staining KitServicebioG1006
Normal SalineServicebioG4702500 mL
ParaformaldehydeBiosharpBL539A4%/500 mL
PBS, 1xServicebioG4202500 mL
Porcine Pancreatic ElastaseSigma AldrichE1250100 mg
Povidine IodineYongan Pharmaceutical Co.Ltd5%/100 mg
Prolene Polypropylene SutureEthicon LLC8709H
Rodent Ultrasound SystemFujifilmVevo 3100LT
Stereo MicroscopeOlympusSZ61
Ultrasonic CouplantKepplerKL-250250 g

References

  1. Chaikof, E. L., et al. The Society for Vascular Surgery practices guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 67 (1), 2-77 (2018).
  2. Johnston, K. W., et al.

Explore More Articles

Abdominal Aortic AneurysmAAA ModelCalcium ChlorideElastase InfiltrationPathophysiological ChangesAnimal ModelsTechnical SimplicityAtherothrombosisAneurysm RupturePeriaortic InfiltrationUltrasound ExperimentsHistological ExperimentsMorphological ChangesPathological Changes

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved